Kamada director discloses option holdings in Form 3

KAMADA LTD director Lilach Payorski has filed an initial Form 3 disclosing option holdings in the company.

Rhea-AI Filing Summary

KAMADA LTD director Lilach Payorski has filed an initial Form 3 disclosing option holdings in the company. The filing reports four grants of options to purchase 7,500 ordinary shares each, covering a total of 30,000 shares at an exercise price of $6.15 per share.

The options are exercisable using a net-exercise method and all expire on June 22, 2029. The tranches become exercisable on December 22, 2023, December 22, 2024, December 22, 2025 and December 22, 2026, respectively. Exercise prices are presented in U.S. dollars based on the Bank of Israel exchange rate as of March 13, 2026.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Payorski Lilach

Role Director

Type	Security	Shares	Price	Value
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--

Holdings After Transaction: Options to purchase Ordinary Shares — 30,000 contracts (Direct)

Footnotes (2)

1. F1. These options to purchase ordinary shares are exercisable using a net-exercise method
2. F2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Lilach Payorski’s Form 3 filing for KAMADA LTD (KMDA) report?

The Form 3 reports Lilach Payorski’s initial holdings of options to purchase KAMADA LTD ordinary shares. It discloses four option grants, each over 7,500 underlying shares, all expiring on June 22, 2029, establishing her derivative equity position as a director.

How many KAMADA LTD shares are covered by Lilach Payorski’s reported options?

The filing shows four option positions, each tied to 7,500 underlying ordinary shares. Together, these options cover 30,000 shares, giving Payorski potential future equity exposure if the options are exercised under their stated terms and conditions.

What is the exercise price of Lilach Payorski’s KAMADA LTD options?

Each reported option grant has an exercise price of $6.15 per share. The filing notes this U.S. dollar figure is a convenience translation from NIS using the Bank of Israel representative exchange rate as of March 13, 2026.

When do Lilach Payorski’s KAMADA LTD options become exercisable and when do they expire?

The options vest in four annual tranches exercisable on December 22, 2023, 2024, 2025 and 2026. All four grants share the same expiration date of June 22, 2029, defining the overall exercise window for these derivative holdings.

How can Lilach Payorski exercise her KAMADA LTD options disclosed in the Form 3?

The footnotes state the options are exercisable using a net-exercise method. Under net exercise, the holder receives fewer shares instead of paying cash, with a portion of the underlying shares effectively used to cover the exercise price obligation.

Does the Form 3 for KAMADA LTD indicate any recent buying or selling by Lilach Payorski?

The Form 3 functions as an initial statement of beneficial ownership and lists existing option holdings. The summarized data show holding entries for derivative securities rather than new open-market purchases or sales of KAMADA LTD ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 09:55 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Payorski Lilach

(Last) (First) (Middle)

215 DERECH HAKORE

(Street)

KFAR MONASH L3 4287500

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/17/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase Ordinary Shares(1)	12/22/2023	06/22/2029	Ordinary Shares	7,500	$6.15(2)	D
Options to purchase Ordinary Shares(1)	12/22/2024	06/22/2029	Ordinary Shares	7,500	$6.15(2)	D
Options to purchase Ordinary Shares(1)	12/22/2025	06/22/2029	Ordinary Shares	7,500	$6.15(2)	D
Options to purchase Ordinary Shares(1)	12/22/2026	06/22/2029	Ordinary Shares	7,500	$6.15(2)	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Lilach Payorski	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.